Foxglove

Digitalis Purpurea

Consult ProfessionalCardiovascular & Blood

Medicinal Facts

Digitalis purpurea, commonly known as foxglove, is renowned for its cardiac glycosides, primarily digoxin and digitoxin, which have potent effects on heart muscle contractility. This plant intersects the worlds of traditional European herbalism, where it was historically used for dropsy and heart conditions, and modern cardiology, where its compounds are critical in managing certain heart diseases. The primary focus is on its ability to modulate cardiac output and rhythm, though its narrow therapeutic window necessitates careful dosing.

What it helps with

Heart failure

Digoxin enhances cardiac contractility by inhibiting the Na+/K+ ATPase pump, leading to increased intracellular calcium concentrations through the Na+/Ca2+ exchanger. This mechanism improves cardiac output and is supported by numerous human trials, forming a cornerstone of heart failure management, particularly in patients with reduced ejection fraction.

Atrial fibrillation

Digoxin is used to control ventricular rate in atrial fibrillation by increasing vagal tone and slowing conduction through the atrioventricular node. This mechanism is well-documented in clinical practice, although its use is often combined with other antiarrhythmics for optimal control.

Edema associated with heart failure

By improving cardiac output, digoxin indirectly reduces the venous pressure that contributes to edema. This effect is a secondary benefit observed in clinical settings, though not the primary indication for digoxin use.

Cardiomyopathy

In cases of dilated cardiomyopathy, digoxin's positive inotropic effect can help maintain cardiac function. While not a first-line treatment, it is used adjunctively, particularly in patients with concurrent atrial fibrillation.

Hypertension

Though not a primary treatment for hypertension, digoxin's effects on cardiac output and renal perfusion can contribute to blood pressure modulation. This is more relevant in heart failure patients with coexisting hypertension.

Congestive heart failure symptoms

Beyond its inotropic effects, digoxin modulates neurohormonal activity, reducing sympathetic activation and renin-angiotensin-aldosterone system activity, which can alleviate symptoms of congestion. This is supported by clinical observations and forms part of comprehensive heart failure management.

Arrhythmias

Digitoxin, similar to digoxin, can be used to manage certain arrhythmias by affecting cardiac electrical activity. Its longer half-life requires careful monitoring, and its use is more limited compared to digoxin.

Key active compounds

Digoxin

A cardiac glycoside that inhibits the Na+/K+ ATPase pump, leading to increased intracellular calcium and enhanced cardiac contractility. It has a narrow therapeutic index, requiring precise dosing and monitoring.

Digitoxin

Similar to digoxin but with a longer half-life, affecting cardiac contractility and rhythm through the same Na+/K+ ATPase inhibition. It is less commonly used due to its prolonged action and risk of accumulation.

Gitoxin

Another cardiac glycoside with similar mechanisms to digoxin and digitoxin, contributing to the overall cardiotonic effects of Digitalis purpurea.

Lanatoside C

A precursor to digoxin, it is metabolized in the body to produce active digoxin, sharing its pharmacological effects.

Lanatoside A

A cardiac glycoside that contributes to the plant's overall effect profile, though less potent than digoxin and digitoxin.

Lanatoside B

Similar to lanatoside A, it plays a role in the cardiotonic activity of the plant, though it is not used therapeutically on its own.

Digitoxigenin

An aglycone component of digitoxin, contributing to the pharmacological activity of cardiac glycosides through its structural role.

What the research says

Research on Digitalis purpurea is heavily centered on its cardiac glycosides, with digoxin being the most extensively studied in human trials for heart failure and atrial fibrillation. These studies confirm its efficacy in improving cardiac output and controlling heart rate, though they highlight the need for careful dosing due to its narrow therapeutic window. Preclinical studies focus on understanding the detailed mechanisms of Na+/K+ ATPase inhibition and its downstream effects on calcium homeostasis and cardiac function. The main limitation of foxglove-derived medications is their narrow therapeutic index and potential for toxicity, which is addressed through careful clinical monitoring and, in some cases, the use of digoxin-specific antibodies in cases of overdose.

Typical dosage

Digitalis purpurea should only be used in standardized pharmaceutical forms, such as digoxin tablets, under medical supervision. Typical dosages for digoxin range from 0.125 to 0.25 mg per day, adjusted based on patient response and serum levels. Regular monitoring of blood levels and kidney function is essential to avoid toxicity.

Log in to view the Apothecary

About Foxglove

Digitalis purpurea, commonly known as foxglove, is a biennial plant native to Europe but widely cultivated in gardens for its striking, tubular flowers. Medicinally, it is renowned for its cardiac glycosides, primarily digoxin and digitoxin, which have potent effects on the heart. These compounds increase the force of heart contractions and are used in the treatment of heart failure and certain arrhythmias. Historically, foxglove has been used since the 18th century when it was first recognized for its ability to treat dropsy (now known as edema related to heart failure). In modern medicine, its derivatives are used under careful medical supervision to manage heart conditions, particularly in patients who do not respond to other treatments. The therapeutic applications of Digitalis purpurea focus on its ability to strengthen cardiac output and regulate heart rhythm. It works by inhibiting the sodium-potassium ATPase pump, leading to an increase in intracellular calcium in heart cells, which enhances cardiac contractility. Despite its efficacy, the plant is highly toxic, and improper use can lead to digitalis toxicity, characterized by nausea, vomiting, diarrhea, confusion, and severe cardiac arrhythmias. Therefore, it is crucial that any medicinal use of foxglove or its derivatives be closely monitored by healthcare professionals. Modern research continues to explore the pharmacokinetics and pharmacodynamics of digitalis compounds, aiming to optimize their therapeutic benefits while minimizing risks. The primary challenge remains the narrow therapeutic window, which necessitates precise dosing and monitoring. As a result, foxglove is a prime example of a plant with significant medicinal value that requires careful handling and respect for its potent effects.

Traditional Use

Digitalis purpurea has been used for centuries, with its medicinal properties documented as early as the 18th century by William Withering, who popularized its use for heart conditions. Traditionally, it has been utilized in European herbal medicine, particularly in the treatment of heart ailments. The plant's use has evolved, with modern medicine recognizing its active compounds for their efficacy in treating heart failure and arrhythmias. Its historical significance is underscored by its role in the development of cardiac pharmacology.

Preparations & Dosage

Preparations

Tincture: Prepare a tincture by soaking dried foxglove leaves in alcohol (ethanol) for several weeks. Strain the liquid and store it in a dark bottle. This method should only be performed by professionals due to the plant's toxicity.
Capsule: Capsules containing standardized doses of digoxin or digitoxin are manufactured under strict pharmaceutical guidelines. These should be taken as prescribed by a healthcare provider.
Standardized extract: Standardized extracts are prepared by pharmaceutical companies to ensure consistent dosing. These extracts are used in clinical settings.

Interactions & Warnings

Digitalis purpurea interacts with a variety of medications, including diuretics, which can cause electrolyte imbalances and increase the risk of toxicity. It also interacts with calcium channel blockers and beta-blockers, which can enhance its effects on heart rate and rhythm. Patients taking antacids or certain cholesterol-lowering drugs may experience reduced absorption of digitalis compounds. Close monitoring and adjustment of dosages are necessary when digitalis is used concomitantly with these medications.

Use with caution

Digitalis purpurea is highly toxic if ingested improperly. It should only be used under strict medical supervision due to the risk of digitalis toxicity, which can cause severe cardiac disturbances and death. Pregnant women, children, and individuals with kidney disease should avoid it.